Wednesday, 5 March 2014 - Société Tunisienne de ... · There will whole one day Practical PD...
Transcript of Wednesday, 5 March 2014 - Société Tunisienne de ... · There will whole one day Practical PD...
Theme of the Congress: Managing Kidney Disease: Quality, Perfection vs. Outcome
Wednesday, 5 March 2014 There will whole one day Practical PD course for restricted number of Attendee 20-30 participants. This will include at the end two important sessions:
i. Meet the Experts and ii. PD in Arabic countries.
Time
Date
10:00 12:45
12:45 13:15
13:15 16:45
17:00 17:30
17:30 19:00
Small Theater
CNE
Coffee Break
CNE Opening
Cermoney Plenary 1
lecture Continuous
Nursing Education
Continuous Nursing
Education
10:00 – 16:45 Pre-Congress CNE / Main Hall
Moderator: Prof. Hussein Sheashaa
10:00 – 16:45 Pre-Congress Continuous Nursing Education /
Lecture Hall
10:00 –16:45 Moderator: Prof: Heba Al-Shaar 10:00 –11:00 Clinical Nephrology TBA 11:00-11:45 HD – Maintenance TBA 11:45-12:00 Coffee Break 12:00-13:00 CRRT & ICU Ib. Sobhy 13:00-14: 00 PD: Initiation & Maintained TBA 14:00-14:30 Lunch 14:30-15:30 Transplantation TBA 15:30-16:30 Practical Training TBA 16:30 – 16:45 Evaluation & Closing Remarks Heba Al. Shaar
Pre-Congress Practical Training / Entrance Hall 10:00 – 16:00
CRRT TBA Alexandria
PD Osama Al-Shaata Mansoura
HD Sherif Aziz Alexandria
USS & Kidney Biopsy Sherif Hegab Alexandria & M. Al-Shafee Alexandria
17:00 – 17:30 Opening Ceremony / Main Hall
Chairpersons: Saeed M. G. Al-Ghamdi, Tarek El-Baz
17:30 – 19:00 Plenary Session / Main Hall
P1: Nephrology 2020 Rashad Barsoum Egypt P2: Role of Antibody in transplant rejection M. Al Sayeg Lebanon
19:00 – 20:00 Oriental Music / Main Hall
Thursday, 6 March 2014
Time
Date
08:00 09:00
0900 10:45
10:45 12:15
12:30 13:30
13:30 15:00
15:00 16:00
16:00 17:30
17:30 19:00
Main Hall
Glo
bal
Kid
ney
Aca
dem
y (G
KA
/OLA
)
Ple
nar
y
Session (S1-DKD)
No
vart
is In
du
stri
al s
ypo
siu
m Session
(S5-G)
Am
gen
Ind
ust
rial
syp
osi
um
Ple
nar
y
CP
C -
1
Small Theater
Session (S2-Tx)
Session (S6-Tx)
Lecture Session (S3-PD)
Session (S7-Bone)
A Session
(S4-Case)
Session (S8-Free
Communications)
Greco Roman
AstraZeneca
industrial lunch
09:00 – 10:45 Plenary Session / Main Hall
Chairpersons: P3: TBA Saeed Al-Ghamdi KSA P4: CKD; Screen or Not- How, Whom and Who? Richard J Glassock USA P5: Membranous nephropathy: from the bench to the bedside? TBA TBA
10:45 – 12:15 Scientific Session (S1) / Main Hall
Diabetic Kidney Disease Moderator: Amr Ebied
1) Immune-Inflammation in DKD; pathogenic role and its therapeutic implications. Amr Ebied Egypt
2) FGF-23: role in progression of DKD.
TBA TBA 3) Tubulo-interstitial fibrosis in DKD. Update in the pathogenesis.
TBA TBA 4) Treatment of Diabetes in CKD – Stage 1-4
Yahiya Ghana Egypt 5) New therapeutic options in DKD
TBA TBA
10:45 – 12:15 Scientific Session (S2) / Small Theater
Transplantation – 1 Moderator: Adel Bakr
1) Bridge to transplant Marwan Al-Masry Lebanon 2) T-reg in Renal Transplant M. Sayeg USA 3) Desensitization TBA TBA 4) Quiz Ahmed Donia Egypt
10:45 – 12:15 Scientific Session (S3) / Lecture Hall
Peritoneal Dialysis Moderator: Salah Naga
1) PD in the challenging population Joanne Bergman Canada 2) The benefits of the new PD Solutions Ali Aboalfa Lebanon 3) Peritonitis management in PD patients: 2013 update Yassin El Shahat UAE 4) PD in AKI Abdalla Alhawish KSA 5) New strategies for growth of PD program Khalid AboSeif Egypt
10:45 – 12:15 Scientific Session (S4) / Hall A
Case presentation Moderators: A. Samy, Hyam AlAggan, Sohair Al-Lakany
Each Case will be selected to presented in 15 min (12 min ppt & 3 min for discussion)
12:30 -13:30 Novartis Industrial Symposium / Main Hall
13:30 – 15:00 Scientific Session (S5) / Main Hall
Glomerular Diseases Moderator: Iman Al-Gohary
The podocytopathies: molecular mechanisms & clinical implications Neveen A Soliman Egypt Immunotactoid vs. Fibrillary GN – A management problem Hayam Al Aggan Egypt Treatment of FSGS – A mysterious Disease to treat? R. Glassock USA New therapy for Glomerular Diseases "Practical or Theoretical – Fact or Fiction" Muhammad Sobh Egypt Stem Cell Therapy in Glomerular Disease: Fact or Fiction? Gamal Al-Saady Egypt
13:30 – 15:00 Scientific Session (S6) / Small Theater
Transplantation – 2 Moderator: Adel Bakr
5) Optimizing graft outcome in renal transplantation: Does Pharmacogenetics has a role?
Antoine Barbari Lebanon 6) Induction in Renal Transplantation – How; When, Which to use? -Does it really have a value? TBA TBA 7) BK in Renal Transplantation - Update
M Ghonimat Jordan 8) Transplant forum
Aymen Refaie Egypt
13:30 – 15:00 Scientific Session (S7) / Lecture Hall
CKD-MBD Moderator: Saeed Al-Ghamdi
1) The initiative factor for CKD-MBD – Does it matter to Know?
TBA TBA 2) Bone of Glass & Heart of Stone
Tarek ElBaz Egypt 3) Phosphate Binders in CKD
Magdy Al Sharkawy Egypt 4) Intravenous alfacalcidol in CKD MBD
Kiriaki Stamatelou Greece 5) (KDIGO) Guidelines for CKD-MBD: Implementation and Adaptation for Practice in the Middle East Countries.
Mona Al Rukhaimi UAE
13:30 – 15:00 Scientific Session (S8) / Hall A Free Paper Communications
Moderators: A. Samy, Hyam AlAggan, Sohair Al-Lakany Chairpersons:
Mini Lecture: Kidney stone disease, epidemiology and latest therapy
Kiriaki Stamatelou Greece
6 papers will be presented. Each paper will be presented for 15min (12 min ppt & 3 min discussion).
15:00 -16:00 Amgen Industrial Symposium / Main Hall
16:00 – 17:30 Plenary Session / Main Hall
Chairpersons: P6: GFR and Albuminuria : Risk Predictors for CKD?
M. El-Nahas UK P7: Advances in immunosuppression therapy monitoring
Marwan Al-Masry Lebnon P8: Nephrotoxicity ,clinical applications
Marc deBroe Belgium
17:30 – 19:00 CPC -1 / Main Hall
Moderators: Clinical Discussant: Assem Al-Sherif
Pathological Discussant: Lina Assad 1st Case: Nahed Baddour Alexandria 2nd Case: TBA TBA 3rd Case: Issam Francis Kuwait 4th Case: TBA Jordon
21:00 – 23:00 Faculty Dinner
Friday, 7 March 2014
Time Date
09:00 10:30
10:30 12:00
12:00 1300
13:00 14:00
14:00 15:30
15:30 16:30
16:30 18:00
Main Hall
Ple
nar
y
Session (S9-HTN)
Coffee Break & Jomaa prayer
San
ofi
ind
ust
ial
sym
po
siu
m
ISN/EDTA
ind
ust
rial
sym
po
siu
m
CP
C -
2 Small
Theater Session
(S10-HD1)
Lecture Session
(S11-Path)
A Session
(S12-Junior)
09:00 – 10:30 Plenary Session / Main Hall
Chair Persons:
P9: Sugar, Uric Acid, Diabetes and Obesity – Do we have a link? RJ Johnson USA
P10: Choosing the Right Dialysis Modality for Each Patient: PD versus HD
Joanne Bergman Canada P11: Maintenance Immunosuppression in Renal Transplantation; does it affect Graft survival?
Maher F. Ramzy Egypt
10:30 – 12:00 Scientific Session (S9) / Main Hall
Hypertension Moderator: Omar Al-Kashab
1) Variability of blood pressure in CKD - impact on prescription
TBA TBA 2) Home blood pressure versus office blood pressure
TBA TBA 3) New guidelines in blood pressure goals in CKD
Omar Al-Kashab Egypt Debate: 4) RAS inhibitors/blockers is the first antihypertensive choice in CKD Pros
Richard Johnson USA 5) RAS inhibitors/blockers is not the first antihypertensive choice in CKD Cons
Meguid El-Nahas UK Rebuttal 5 min each Vote 5 min
10:30 – 12:00 Scientific Session (S10) / Small Theater
Hemo-Dialysis/CRRT-1 Moderator: Waleed Masoud
1) Intra and inter dialytic Na and volume control
Sohair Al-Lakany Egypt 2) Optimizing removal of middle and large uremic toxins: role of membrane, treatment modality and time
B. Canaud France 3) Are we preparing the patient for hemodialysis in Egypt: Preparation of the patient for hemodialysis:
Guidelines vs. TBA TBA Egypt vs. Waleed Masoud Egypt Voting TBA TBA
4) AVF Button Technique
M. Jadoul France
10:30 – 12:00
Scientific Session (S11) / Lecture Hall Renal Pathology
Moderator: Issam Francis, Lina Assad, Wesam Ismail Chairpersons:
1) C3 GN – Update in MPGN Classification– Pathological View Fatma Al Huseiny Egypt 2) Interstitial Nephritis – pathological entity without boundaries
TBA TBA 3) Hereditary Nephritis – Does Pathology help?
TBA TBA 4) Pathological Case (1)
Lina Assad Syria
5) Pathological Case (2) Wesam Ismail Egypt
10:30 – 12:00 Scientific Session (S12) / Hall A
Free Junior Communications Moderators: Hussein Sheashaa, M. Salah, A. Adam
9 free junior communications will be selected to be presented.
Each presentation will take 10 min (8 min ppt & 2 min Discussion)
12:00 – 13:00 Coffee Break & Gomaa Pray
13:00 - 14:00
Sanofi Industrial Symposium / Main Hall
14:00 – 15:30 ISN / EDTA Satellite Session / Main Hall
Chairperson: G Remuzzi Italy
DOPPS – Update Michel Jadoul Belgium
Onco-nephrology: glomerular diseases with cancer.
TBA TBA Donor / Recipient relationship in renal transplantation in the Arabic world
Mona Al Rukhaimi UAE "0 by 25" A human rights case for health equity: acute kidney failure in poor countries should no longer be a death sentence"
G Remuzzi Italy
15:30 - 16:30 Industrial Symposium / Main Hall
16:30 – 18:00 CPC -2 / Main Hall
Moderators: Clinical Discussant: Riyad Said Jordon
Pathological Discussant: Issam Francis Kuwait 5th Case: TBA Mansoura 6th Case: TBA Cairo 7th Case: TBA KSA 8th Case: TBA Ein Shams
21:00 – 23:00 Gala Dinner Friday
Saturday, 8 March 2014
Time
Date
0900 10:45
10:45 11:45
11:45 12:15
12:15 14:15
14:15
Main Hall
Ple
nar
y C
losi
ng
Rem
arks
Kid
ney
Fo
rum
Co
ffee
Bre
ak
Session (S13-Prog)
Dep
artu
re
Small Theater Session
(S14-Epidemiology)
Lecture Session
(S15-WKD)
A Session
(S16-HD2-CRRT)
09:00 – 10:45 Plenary Session / Main Hall
Chairpersons:
P12: The impact of viruses and their treatment on the kidney Michel Jadoul Belgium
P13: APK; still Unsolved Management Problem?
G. Remuzzi Italy P14: The Transplantation in the Arabic World
Faisel Shaeen KSA
10:45 – 11:45 Kidney Forum / Main Hall Chairpersons: R. Barsoum
Clinical Discussant: M. Jadoul & Antoine Barbari Pathological Discussant: Mona Salem & Wesam Ismail
11:45 – 12:00
Closing Remarks / Main Hall Charipersons: Tarek ElBaz, G. Remuzzi
12:15 – 14:15 Scientific Session (S13) / Main Hall
Progression of CKD - CKD: Contrarian Views! Moderator: Abdel Meguid El-Nahas
1) Progression, remission and regression of chronic renal diseases and the case of kidney self-repair
G. Remuzzi Italy 2) Reflections on with Current CKD Guidelines
Richard Glassock USA
3) CKD – Care Pathway? Marc de Broe Belgium
4) eGFR: What for?
Abdel Meguid El Nahas UK 5) Genetics of CKD; Does it help to Manage Progression?
Neveen Soliman ElShakhs Egypt
12:15 – 14:15 Scientific Session (S14) / Small Theater
Epidemiology of Kidney Diseases Moderator: Hala El-Wakeel
1) Non-Communicable diseases as global and regional problems.
Alaa Alwan EMRO-WHO 2) Screening for CKD in KSA as a part of the Arabic World.
TBA TBA 3) Kidney protection program in Alexandria region "KIPP-Alex".
Hala El-Wakil Egypt 4) Control Program for non-communicable diseases- Environmental-Health Link.
Moustafa Mourad HIPH- Alex
12:15 – 14:15 Scientific Session (S15) / Lecture Hall
WKD – 2014 – “ CHRONIC KIDNEY DISEASE AND AGING”. Moderator: Hany Hafez
Chairpersons: 1) Introduction :Various scientific activities of ESNT
Tarek El-Baz Egypt 2) What Did World Kidney Days added (Flash back of last 5 years activities)
Mohamed Hani Hafez Egypt
3) How Aging Affects Normal Kidneys. TBA TBA
4) CKD patients & aging : specific Considerations for CKD, Dialysis & Transplantation populations
Richard Glassock USA
12:15 – 14:15 Scientific Session (S16) / Hall A
Hemo-Dialysis- 2 AKI- CRRT- ICU Nephrology Moderator: Montassar Zeid
Chairpersons: Bioimpedence in HD Ahmed Samy ElBelbessy Egypt Concurrent CRRT and therapeutic plasma exchange Montassar Zeid Egypt Extended indications for CRRT Saeed Khamis Egypt Dialysis dose controversy: what role for Kt/V in future ? G Canaud France